lebrikizumab (LY3650150) - Roche, Almirall, Eli Lilly
Adbry (tralokinumab) - LEO Pharma, AstraZeneca
eblasakimab (ASLAN004) - ASLAN Pharma
http://www.ncbi.nlm.nih.gov/pubmed/35081849
 
Jan 28, 2022
 
Prev Next